(AOF) – 3M announced today that its board of directors has approved plans to spin off its healthcare business, which will be known as Solventum Corporation. The company is expected to separate from 3M on April 1, 2024 and has applied to list on the New York Stock Exchange under the name “SOLV”. “Today’s approval is another important milestone as we continue to make progress in building two world-class companies, both positioned to continue their respective growth and tailored capital allocation plans,” said Mike Roman, CEO.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
